Filing Details

Accession Number:
0001062993-22-021637
Form Type:
13D Filing
Publication Date:
2022-11-06 19:00:00
Filed By:
Saba Capital
Company:
Saba Capital Income & Opportunities Fund Ii (NYSE:SABA)
Filing Date:
2022-11-07
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Saba Capital Management 0 37,774,074 0 37,774,074 37,774,074 36.77%
Boaz R. Weinstein 0 37,774,074 0 37,774,074 37,774,074 36.77%
Saba Capital Management GP 0 37,774,074 0 37,774,074 37,774,074 36.77%
Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D/A

 

Under the Securities Exchange Act of 1934

(Amendment No. 18)*

 

Templeton Global Income Fund

(Name of Issuer)

 

Common Shares, No par value

(Title of Class of Securities)

 

880198106

(CUSIP Number)

Saba Capital Management, L.P.

405 Lexington Avenue

58th Floor

New York, NY 10174

Attention: Michael D'Angelo

(212) 542-4635

(Name, Address and Telephone Number of Person

Authorized to Receive Notices and Communications)

 

November 3, 2022

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [X]

(Page 1 of 7 Pages)

______________________________

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No.  880198106 SCHEDULE 13D/A Page 2 of 7 Pages

1

NAME OF REPORTING PERSON

Saba Capital Management, L.P.

2

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) ☐

(b) ☐

3

  SEC USE ONLY

 

4

SOURCE OF FUNDS

OO (see Item 3)

5

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

37,774,074

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

37,774,074

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

37,774,074

12

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

36.77%

14

TYPE OF REPORTING PERSON

PN; IA

The percentages used herein are calculated based upon 102,721,927 shares of common stock outstanding as of 6/30/22, as disclosed in the company's N-CSRS filed 8/29/2022.

CUSIP No.  880198106 SCHEDULE 13D/A Page 3 of 7 Pages

1

NAME OF REPORTING PERSON

Boaz R. Weinstein

2

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) ☐

(b) ☐

3

  SEC USE ONLY

 

4

SOURCE OF FUNDS

OO (see Item 3)

5

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION

United States

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

37,774,074

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

37,774,074

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

37,774,074

12

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

36.77%

14

TYPE OF REPORTING PERSON

IN

The percentages used herein are calculated based upon 102,721,927 shares of common stock outstanding as of 6/30/22, as disclosed in the company's N-CSRS filed 8/29/2022.

CUSIP No.  880198106 SCHEDULE 13D/A Page 4 of 7 Pages

1

NAME OF REPORTING PERSON

Saba Capital Management GP, LLC

2

  CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

(a) ☐

(b) ☐

3

  SEC USE ONLY

 

4

SOURCE OF FUNDS

OO (see Item 3)

5

  CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)

 

6

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:

7

SOLE VOTING POWER

-0-

8

SHARED VOTING POWER

37,774,074

9

SOLE DISPOSITIVE POWER

-0-

10

SHARED DISPOSITIVE POWER

37,774,074

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

37,774,074

12

  CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES

 

13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

36.77%

14

TYPE OF REPORTING PERSON

OO

The percentages used herein are calculated based upon 102,721,927 shares of common stock outstanding as of 6/30/22, as disclosed in the company's N-CSRS filed 8/29/2022.

CUSIP No.  880198106 SCHEDULE 13D/A Page 5 of 7 Pages

Item 1.

SECURITY AND ISSUER

 

 

 

This Amendment No. 18 amends and supplements the statement on Schedule 13D filed with the SEC on 11/18/20, as amended by Amendment No. 1 filed 12/9/20, Amendment No. 2 filed 12/16/20, Amendment No. 3 filed 12/28/20, Amendment No. 4 filed 12/29/20, Amendment No. 5 filed 1/14/21, Amendment No. 6 filed 1/29/21, Amendment No. 7 filed 5/12/21, Amendment No. 8 filed 7/9/21, Amendment No. 9 filed 7/27/21, Amendment No. 10 filed 8/10/21, Amendment No. 11 filed 11/29/21, Amendment No. 12 filed 12/16/21, Amendment No. 13 filed 12/28/21, Amendment No. 14 filed 6/7/22, Amendment No. 15 filed 7/14/22, Amendment No. 16 filed 8/23/22, and Amendment No. 17 filed 9/21/22; with respect to the common shares of Templeton Global Income Fund.  This Amendment No. 18 amends Items 3 and 5, as set forth below. 

   
Item 3.

SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION 

Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors and the capital appreciation thereon and margin account borrowings made in the ordinary course of business.  In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time.  Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein. A total of approximately $187,147,485 was paid to acquire the Common Shares reported herein.


Item 5.

INTEREST IN SECURITIES OF THE ISSUER

   

(a)

See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons.  The percentages used herein are calculated based upon 102,721,927 shares of common stock outstanding as of 6/30/22, as disclosed in the company's N-CSRS filed 8/29/2022.

 

 

(b)

See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.

 

 

(c)

The transactions in the Common Shares effected since the Schedule 13D/A filing on 9/21/22 by the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference.

 

 

(d)

The funds and accounts advised by Saba Capital have the right to receive the dividends from and proceeds of sales from the Common Shares.

 

 

(e)

Not applicable.


CUSIP No.  880198106 SCHEDULE 13D/A Page 6 of 7 Pages

SIGNATURES

After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date:  November 7, 2022

 

SABA CAPITAL MANAGEMENT, L.P. 

By:  /s/ Michael D'Angelo

 

Name: Michael D'Angelo

Title: Chief Compliance Officer

 

 

 

 

 

SABA CAPITAL MANAGEMENT GP, LLC 

By:  /s/ Michael D'Angelo

Name: Michael D'Angelo

Title: Authorized Signatory

 

 

 

 

 

BOAZ R. WEINSTEIN 

By:  /s/ Michael D'Angelo

 

Name: Michael D'Angelo

 

Title: Attorney-in-fact*

 

* Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 

 


CUSIP No.  880198106 SCHEDULE 13D/A Page 7 of 7 Pages

Schedule A

This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D/A on 9/21/22. All transactions were effectuated in the open market through a broker.

Trade Date

Buy/Sell

Shares

Price

9/21/2022

Buy

25,876

4.49

9/22/2022

Buy

5,900

4.45

9/22/2022

Buy

14,361

4.46

9/23/2022

Buy

84,322

4.34

9/26/2022

Buy

48,988

4.25

9/27/2022

Buy

71,100

4.21

9/28/2022

Buy

20,816

4.26

9/29/2022

Buy

38,942

4.21

10/7/2022

Buy

29,145

4.24

10/7/2022

Buy

40,000

4.27

10/10/2022

Buy

7,888

4.29

10/11/2022

Buy

50,751

4.23

10/12/2022

Buy

20,376

4.17

10/13/2022

Buy

73,594

4.18

10/14/2022

Buy

70,043

4.07

10/17/2022

Buy

45,892

4.15

10/18/2022

Buy

4,685

4.09

10/18/2022

Buy

900

4.10

10/18/2022

Buy

139,804

4.06

10/18/2022

Buy

20,000

4.06

10/19/2022

Buy

31,952

4.05

10/20/2022

Buy

36,067

4.07

10/21/2022

Buy

45,493

4.09

10/24/2022

Buy

14,738

4.05

10/27/2022

Buy

60,811

4.2

11/2/2022

Buy

100

4.12

11/3/2022

Buy

56,301

4.13